Responding to the threat of bioterrorism: A microbial ecology perspective - The case of anthrax

International Microbiology

Volumn 5, Issue 4, 2002, Pages 161-167

  Atlas, R M ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Bacillus anthracis; Biological weapons; Bioterrorism; Ciprofloxacin; Endospores

Indexed keywords

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); BOS TAURUS; EQUIDAE; EQUUS CABALLUS; OVIS ARIES; POSIBACTERIA; SUS SCROFA;

ANTHRAX VACCINE;

ANTHRAX; BACILLUS ANTHRACIS; BACTERIAL SPORE; BIOLOGICAL WARFARE; DISASTER PLANNING; ECOLOGY; GROWTH, DEVELOPMENT AND AGING; HUMAN; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; REVIEW; ULTRASTRUCTURE;

ANTHRAX; ANTHRAX VACCINES; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; BIOTERRORISM; DISASTER PLANNING; ECOLOGY; HUMANS; SPORES, BACTERIAL;

EID: 0036886569     PISSN: 11396709     EISSN: 16181905     Source Type: Journal    
DOI: 10.1007/s10123-002-0084-x     Document Type: Review

References (28)

1. Atlas RM (1998) The medical threat of biological weapons. Crit Rev Microbiol 24:157-168
2. Atlas RM (1998) Biological weapons pose challenge for microbiology community. ASM News 64:383-389
3. Atlas RM (2001) Bioterrorism before and after September, 11. Crit Rev Microbiol 27:355-379
4. Barnaby W (1997) Biological weapons: an increasinc threat. Med Confl Surviv 13:301-313
5. Brachman P, Pagano J, Albrink W (1961) Two cases of fatal inhalation anthrax, one associated with sarcoidosis, N Engl J Med 265:203-208
6. Brooksher W, Briggs J (1920) Pulmonary anthrax: report of a case JAMA 74:323-324
7. Cowdery J (1947) Primary pulmonary anthrax with septicemia. Arch Pathol 43:396-399
8. Fletcher J (2000) Human Anthrax in the United States: a descriptive review of case reports, 1955-1999. Rollins School of Public Health, Atlanta, Georgia
9. Franz DR, Jahrling PB, Friedlander A, et al. (1997) Clinical recognition and management of patients exposed to biological warfare agents. JAMA 278:399-411
10. Gold H (1955) Anthrax: a report of one hundred seventeen cases. Arch Intern Med 96:387-396
11. Hansen JE (1999) Viruses, bacteria, and toxins as biological warfare. Urgeskr Laeger 161:772-775 [In Danish]
12. Henderson DA (1998) Bioterrorism as a public health threat. Emerg Infect Dis 4:488-492
13. Henderson DA (1999) The looming threat of bioterrorism. Science 283:1279-1282
14. Inglesby TV, Henderson DA, Barylett JG, et al. (1999) Anthrax as biological weapon. Medical and public health management. Working group on civilian biodefense. JAMA 281:1735-1745
15. Ivins BE, Fellows PF, Pitt MLM, et al. (1996) Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol challenge in rhesus monkeys. Salisbury Med Bull 87(Suppl.):125-126X
16. Krane S (1957) Cases from the medical grand rounds of the Massachusetts General Hospital, case 388: sinusitis due to anthrax. Amer Pract Dig Treat 8:1628-1636
17. Kelly DJ, Chulay JD, Mikesell P, Friedlander AM (1992) Serum concentrations of penicillin, doxycycline, and ciprofloxacin during prolonged therapy in rhesus monkeys. J Infect Dis 166:1184-1187
18. Laforce F (1978) Woolsorter's disease in England. Bull NY Acad Sci 54:956-963
19. LaForce F, Bumford B, Feeley JC, Stokes SL, Snow DB (1969) Epidemiologic study of a fatal case of inhalation anthrax. Arch Environ Health 18:798-805
20. Levinsky W, Anderson T, Ricardson G (1954) Inhalation anthrax meningitis and bacillemia: a case report. In: Proceedings of the Symposium on Anthrax in Man. Philadelphia, Pennsylvania, pp 96-103
21. Liddingtong RC (2002) The crystal structure of the final component of the three part anthrax toxin using that molecule to stimulate its own activity. Nature 415:373-374
22. Pile JC, Malone JD, Eitzen EM, Friedlander AM (1998) Anthrax as a potential biological warfare acent. Arch Intern Med 158:429-434
23. Plotkin S, Brachman P, Utell M, Bumford F, Atchison M (1960) An epidemic of inhalation anthrax, the first in the twentieth century, I. Clinical features. Am J Med 29:992-1001
24. Schupp JM, Klevytska AM, Zinser G, Price LB, Keim P (2000) vrrB, a hypervariable open reading frame in Bacillus anthracis. J Bacteriol 182:3989-3997
25. Shafazand S, Doyle R, Ruoss S, Weinacker A, Raffin TA (1999) Inhalational anthrax: epidemology, diagnosis, and management. Chest 116:1369-1376
26. Slater MS, Trunkey DD (1997) Terrorism in America. An evolving threat. Arch Surg 132:1059-1066
27. Titball RW, Turnbull PC, Hutson RA (1991) The monitoring and detection of Bacillus anthracis in the environment. J Appl Bacteriol 70(Suppl.):S9-S18
28. Turnbull PC (1991) Anthrax vaccines: past, present and future. Vaccine 9:533-539